(Q80027680)

English

Efficacy of single dose pegfilgrastim in enhancing the mobilization of CD34+ peripheral blood stem cells in aggressive lymphoma patients treated with cisplatin-aracytin-containing regimens

scientific article published on 31 July 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16878144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Efficacy of single dose pegfilgrastim in enhancing the mobilization of CD34+ peripheral blood stem cells in aggressive lymphoma patients treated with cisplatin-aracytin-containing regimens (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16878144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Nosari A

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16878144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Cairoli R

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16878144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Ciapanna D

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16878144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Gargantini L

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16878144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Intropido L

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16878144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Baraté C

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16878144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Scarpati B

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16878144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Santoleri L

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16878144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Nador G

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16878144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Pezzetti L

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16878144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Morra E

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16878144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

31 July 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16878144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Bone Marrow Transplantation

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16878144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

38

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16878144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

413-416

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16878144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16878144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705459

0 references

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705459

7 January 2021

based on heuristic

inferred from DOI database lookup

Neulasta (pegfilgrastim): a once-per-cycle option for the management of chemotherapy-induced neutropenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705459

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, multicenter, open-label study of pegfilgrastim compared with daily filgrastim after chemotherapy for lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705459

7 January 2021

based on heuristic

inferred from DOI database lookup

Open-label, Randomized Study of Pegfilgrastim vs. Daily Filgrastim as an Adjunct to Chemotherapy in Elderly Patients with Non-Hodgkin's Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705459

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705459

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705459

7 January 2021

based on heuristic

inferred from DOI database lookup

A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705459

7 January 2021

based on heuristic

inferred from DOI database lookup

The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705459

7 January 2021

based on heuristic

inferred from DOI database lookup

The utilization of cytokines in stem cell mobilization strategies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705459

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of filgrastim for stem cell mobilisation and transplantation in high-dose cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705459

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705459

7 January 2021

based on heuristic

inferred from DOI database lookup

Fixed-dose pegfilgrastim is safe and allows neutrophil recovery in patients with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705459

7 January 2021

based on heuristic

inferred from DOI database lookup

A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705459

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80027680&oldid=1756914250"